Tonix Pharmaceuticals (TNXP) Stock: Gaining On Patient Enrollment
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) is flying early on in the trading session this morning, and for good reason. The company announced its first patient enrollment in a Phase 3 clinical trial. Of course, the news excited investors who are pushing the stock on a run for the top. Today, we’ll talk about: The … Read more